HIGHLIGHTS
- who: Mario Luca Morieri et al. from the Department of Medicine, University of Padova, Padua, Italy have published the research: Pharmacogenetics of Cardiovascular Prevention in Diabetes: From Precision Medicine to Identification of Novel Targets, in the Journal: (JOURNAL) of 25/07/2022
- what: The aim of precision medicine is to identify subgroups of subjects iations. Given the established causal role of LDL cholesterol (LDLc) on CVD, the first goal of LLT is to achieve LDLc targets using statins plus ezetimibe and/or PCSK9i when needed .
- how: Most of these studies were conducted in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.